Cargando…
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis
BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia (AE-UCIIP) remain to be elucidated. The aim of thi...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328360/ https://www.ncbi.nlm.nih.gov/pubmed/32600180 http://dx.doi.org/10.1177/1753466620935774 |
_version_ | 1783552720596107264 |
---|---|
author | Enomoto, Noriyuki Naoi, Hyogo Aono, Yuya Katsumata, Mineo Horiike, Yasuoki Yasui, Hideki Karayama, Masato Hozumi, Hironao Suzuki, Yuzo Furuhashi, Kazuki Fujisawa, Tomoyuki Inui, Naoki Nakamura, Yutaro Suda, Takafumi |
author_facet | Enomoto, Noriyuki Naoi, Hyogo Aono, Yuya Katsumata, Mineo Horiike, Yasuoki Yasui, Hideki Karayama, Masato Hozumi, Hironao Suzuki, Yuzo Furuhashi, Kazuki Fujisawa, Tomoyuki Inui, Naoki Nakamura, Yutaro Suda, Takafumi |
author_sort | Enomoto, Noriyuki |
collection | PubMed |
description | BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia (AE-UCIIP) remain to be elucidated. The aim of this study was to clarify the clinical features and prognosis of AE-UCIIP compared with those of AE-IPF. METHODS: In 187 patients with UCIIP or IPF, 64 patients with AE-UCIIP or AE-IPF, who were diagnosed and treated at our hospital, were retrospectively evaluated. RESULTS: A total of 24 patients with AE-UCIIP were significantly older (p = 0.011), included more women (p < 0.001) and never-smokers (p < 0.001), and showed fewer lung lesions on high-resolution computed tomography (p = 0.006) than 40 patients with AE-IPF. Incidence of AE-UCIIP was 10.29%/year and was significantly higher than in AE-IPF (Gray’s test, p = 0.008). Prognosis of AE-UCIIP was as poor as that of AE-IPF (log-rank, p = 0.681). Percent-predicted forced vital capacity (%FVC) [hazard ratio (HR) 0.934, p = 0.045], and GAP stage within 12 months before AE (HR 3.530, p = 0.023), and partial pressure arterial oxygen/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio at AE (HR 0.998, p = 0.016) were significant prognostic factors. Finally, commencement of long-duration (⩾12 h) direct hemoperfusion with a polymyxin B-immobilised fibre column (PMX-DHP) within 2 days after admission significantly improved survival (log-rank, p = 0.038) and was a significant prognostic factor (HR 0.175, p = 0.0039) in AE-UCIIP. Long-duration PMX-DHP showed favourable treatment effects even in the combined group of patients with AE-UCIIP or AE-IPF (log-rank p = 0.002; HR 0.328, p = 0.006). CONCLUSIONS: Patients with AE-UCIIP were older and included more women and never-smokers than those with AE-IPF. Prognosis of AE-UCIIP was as poor as that of AE-IPF. The reviews of this paper are available via the supplemental material section. |
format | Online Article Text |
id | pubmed-7328360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-73283602020-07-09 Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis Enomoto, Noriyuki Naoi, Hyogo Aono, Yuya Katsumata, Mineo Horiike, Yasuoki Yasui, Hideki Karayama, Masato Hozumi, Hironao Suzuki, Yuzo Furuhashi, Kazuki Fujisawa, Tomoyuki Inui, Naoki Nakamura, Yutaro Suda, Takafumi Ther Adv Respir Dis Original Research BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is well known as a life-threatening condition during its clinical course. However, the clinical features and prognosis in AE of unclassifiable idiopathic interstitial pneumonia (AE-UCIIP) remain to be elucidated. The aim of this study was to clarify the clinical features and prognosis of AE-UCIIP compared with those of AE-IPF. METHODS: In 187 patients with UCIIP or IPF, 64 patients with AE-UCIIP or AE-IPF, who were diagnosed and treated at our hospital, were retrospectively evaluated. RESULTS: A total of 24 patients with AE-UCIIP were significantly older (p = 0.011), included more women (p < 0.001) and never-smokers (p < 0.001), and showed fewer lung lesions on high-resolution computed tomography (p = 0.006) than 40 patients with AE-IPF. Incidence of AE-UCIIP was 10.29%/year and was significantly higher than in AE-IPF (Gray’s test, p = 0.008). Prognosis of AE-UCIIP was as poor as that of AE-IPF (log-rank, p = 0.681). Percent-predicted forced vital capacity (%FVC) [hazard ratio (HR) 0.934, p = 0.045], and GAP stage within 12 months before AE (HR 3.530, p = 0.023), and partial pressure arterial oxygen/fraction of inspired oxygen (PaO(2)/FiO(2)) ratio at AE (HR 0.998, p = 0.016) were significant prognostic factors. Finally, commencement of long-duration (⩾12 h) direct hemoperfusion with a polymyxin B-immobilised fibre column (PMX-DHP) within 2 days after admission significantly improved survival (log-rank, p = 0.038) and was a significant prognostic factor (HR 0.175, p = 0.0039) in AE-UCIIP. Long-duration PMX-DHP showed favourable treatment effects even in the combined group of patients with AE-UCIIP or AE-IPF (log-rank p = 0.002; HR 0.328, p = 0.006). CONCLUSIONS: Patients with AE-UCIIP were older and included more women and never-smokers than those with AE-IPF. Prognosis of AE-UCIIP was as poor as that of AE-IPF. The reviews of this paper are available via the supplemental material section. SAGE Publications 2020-06-29 /pmc/articles/PMC7328360/ /pubmed/32600180 http://dx.doi.org/10.1177/1753466620935774 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Enomoto, Noriyuki Naoi, Hyogo Aono, Yuya Katsumata, Mineo Horiike, Yasuoki Yasui, Hideki Karayama, Masato Hozumi, Hironao Suzuki, Yuzo Furuhashi, Kazuki Fujisawa, Tomoyuki Inui, Naoki Nakamura, Yutaro Suda, Takafumi Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis |
title | Acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis |
title_full | Acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis |
title_fullStr | Acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis |
title_full_unstemmed | Acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis |
title_short | Acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis |
title_sort | acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328360/ https://www.ncbi.nlm.nih.gov/pubmed/32600180 http://dx.doi.org/10.1177/1753466620935774 |
work_keys_str_mv | AT enomotonoriyuki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT naoihyogo acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT aonoyuya acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT katsumatamineo acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT horiikeyasuoki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT yasuihideki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT karayamamasato acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT hozumihironao acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT suzukiyuzo acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT furuhashikazuki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT fujisawatomoyuki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT inuinaoki acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT nakamurayutaro acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis AT sudatakafumi acuteexacerbationofunclassifiableidiopathicinterstitialpneumoniacomparisonwithidiopathicpulmonaryfibrosis |